Utah Medical Products Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	13.87	16.64	16.47	14.79
Depreciation & Amortization	2.85	6.37	7.08	7.28
Stock-Based Compensation	0.26	0.23	0.18	0.17
Provision & Write-off of Bad Debts	-0	-0.03	0.03	0.02
Other Operating Activities	-0.36	-0.69	-0.4	-0.09
Change in Accounts Receivable	-0.84	2.27	-0.51	-1.09
Change in Inventory	0.59	-0.67	-2.35	-0.49
Change in Accounts Payable	-0.07	-0.46	0.46	-0.02
Change in Other Net Operating Assets	-1.48	-1.38	0.17	0.59
Operating Cash Flow	14.83	22.28	21.15	21.2
Operating Cash Flow Growth	-33.44%	5.36%	-0.26%	5.29%
Capital Expenditures	-0.23	-0.64	-0.81	-0.55
Sale of Property, Plant & Equipment	0.03	-	-	-
Sale (Purchase) of Intangibles	-0.01	-	-0.01	-
Investing Cash Flow	-0.21	-0.64	-0.82	-0.55
Issuance of Common Stock	0.39	0.12	0.17	0.56
Repurchase of Common Stock	-19.97	-	-2.5	-
Common Dividends Paid	-4.26	-4.28	-3.16	-11.47
Financing Cash Flow	-23.84	-4.17	-5.48	-10.91
Foreign Exchange Rate Adjustments	-0.68	0.34	-0.77	-0.36
Net Cash Flow	-9.89	17.82	14.08	9.38
Free Cash Flow	14.6	21.64	20.34	20.65
Free Cash Flow Growth	-32.53%	6.41%	-1.52%	7.13%
Free Cash Flow Margin	35.70%	43.09%	38.90%	42.10%
Free Cash Flow Per Share	4.17	5.95	5.58	5.64
Cash Income Tax Paid	4.64	4.83	4.97	4.62
Levered Free Cash Flow	11.74	17.69	18.35	17.14
Unlevered Free Cash Flow	11.74	17.69	18.35	17.14
Change in Working Capital	-1.8	-0.23	-2.23	-1.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.